Teijin Pharma Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 20,000

Employees

  • Investments
  • 8

Teijin Pharma General Information

Description

Manufacturer of pharmaceutical and home healthcare products created to prevent bone and joint, respiratory, and cardiovascular and metabolic diseases. The company provides pharmaceutical drugs, sonic accelerated fracture healing system, oxygen concentrator and airway pressure device, enabling patients to have an improved quality of life through antihyperuricemic treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kasumigaseki Common Gate West Building
  • 3-2-1 Kasumigaseki, Chiyoda-ku
  • Tokyo, 100-8585
  • Japan
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Kasumigaseki Common Gate West Building
  • 3-2-1 Kasumigaseki, Chiyoda-ku
  • Tokyo, 100-8585
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teijin Pharma Patents

Teijin Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025068805-A Patient information sharing system, patient information sharing method, patient information sharing program, and managing physician terminal device Pending 17-Oct-2023
JP-2025025915-A Light therapy device Pending 10-Aug-2023
US-20240415464-A1 Mental disorder determination device, terminal device, classifier, mental disorder determination assistance method, and recording medium Pending 15-Jun-2023
JP-2024179550-A Mental disease determination device, learned model, mental disease determination assistance method, program, and terminal device Pending 15-Jun-2023
JP-2024179548-A Noise determination device, hybrid model, noise determination method, program, and terminal device Pending 15-Jun-2023
To view Teijin Pharma’s complete patent history, request access »

Teijin Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teijin Pharma Investments & Acquisitions (8)

Teijin Pharma’s most recent deal was a Later Stage VC with Mealthy for . The deal was made on 31-May-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mealthy 31-May-2021 Later Stage VC Other Healthcare Services
Takeda Pharmaceutical (4 Diabetes Products) 01-Apr-2021 Corporate Asset Purchase Buildings and Property
Kyorin Holdings 05-Jun-2014 Secondary Transaction - Private Pharmaceuticals
Kyorin Holdings 02-Apr-2013 Secondary Transaction - Private Pharmaceuticals
Esteve Teijin Healthcare 01-Feb-2009 Joint Venture Managed Care
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Teijin Pharma FAQs

  • When was Teijin Pharma founded?

    Teijin Pharma was founded in 2002.

  • Where is Teijin Pharma headquartered?

    Teijin Pharma is headquartered in Tokyo, Japan.

  • What is the size of Teijin Pharma?

    Teijin Pharma has 20,000 total employees.

  • What industry is Teijin Pharma in?

    Teijin Pharma’s primary industry is Drug Discovery.

  • Is Teijin Pharma a private or public company?

    Teijin Pharma is a Private company.

  • What is Teijin Pharma’s current revenue?

    The current revenue for Teijin Pharma is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »